Temple researchers to explore ability of compounds to protect brain against HIV infection

(Temple University Health System) Antiretroviral drugs can greatly increase life expectancy for patients infected with HIV. However, the drugs cannot completely eliminate the virus. Hidden away in cells, latent HIV gains access to the brain, causing a debilitating syndrome known as HIV-associated neurocognitive disorder (HAND). Compounds known as cannabinoid receptor type 2 agonists may be able to stop HAND from developing. Thanks to new funding, researchers at Lewis Katz School of Medicine at T...